← SynDRA

FASIGLIFAM

SynDRA canonical compound SYN0027797 — structure-anchored drug synonym record

All known targets

• FFAR1
• INS

Mechanisms of action (all sources)

• Insulin secretagogue
• FFAR1 POSITIVE ALLOSTERIC MODULATOR
• Free fatty acid receptor 1 positive allosteric modulator
• FFAR1 MODULATOR

Cross-references

• PubChem CID: 57339446
• ChEMBL: CHEMBL1829174
• DrugBank: DB12491
• ChEBI: 177451
• KEGG: D10336
• PDB: 2YB
• TTD: D0M0WV
• LINCS BRD: BRD-K58501140

Synonyms

• FASIGLIFAM HYDRATE
• FASIGLIFAM HEMIHYDRATE
• TAK-875 ANHYDROUS
• AK875
• CPD 9A
• TAK-875
• TAK875
• Fasiglifam hemihydrate
• UNII-8LDT91CH8A
• 8LDT91CH8A
• TAK-875 Hemihydrate
• Fasiglifam hydrate (JAN)
• DTXSID80160191
• MolPort-035-395-707
• EX-A2165
• s2637
• AKOS025404925
• 3-Benzofuranacetic acid, 6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)(1,1'-biphenyl)-3-yl)methoxy)-2,3-dihydro-, hydrate (2:1), (3S)-
• (3S)-6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy) biphenyl-3-yl)methoxy)-2,3-dihydro-l-benzofuran-3-yl)acetic acid hydrate
• SC-95595
• BC600332
• (3S)-6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)
• TAK 875
• UNII-GLP1W4JXAH
• GLP1W4JXAH
• (S)-2-(6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid
• CHEMBL1829174
• [(3s)-6-({2',6'-Dimethyl-4'-[3-(Methylsulfonyl)propoxy]biphenyl-3-Yl}methoxy)-2,3-Dihydro-1-Benzofuran-3-Yl]acetic Acid
• 3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)-
• J-501277
• Tak-875 anhydrous
• fasiglifamum
• RefChem:921483
• DTXCID301509991
• TAK-875(Fasiglifam)
• MFCD18251445
• C29H32O7S
• Fasiglifam [INN]
• Fasiglifam [USAN:INN]